ESMO 2022 Conference Coverage
A

ESMO 2022 on the Phase III ERMES Study: FOLFIRI/Cetuximab vs. FOLFIRI/Cetuximab Followed by Cetuximab Alone in 1L Therapy of RAS and BRAF Wild-Type mCRC

By ESMO 2022 Conference Coverage FEATURING Armando Orlandi
By ESMO 2022 Conference Coverage FEATURING Armando Orlandi
219 views
September 27, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Related Videos

17:19

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

2.1K views
03:08

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

720 views
14:19

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

432 views
18:21

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

465 views
22:55

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

3.1K views
04:40

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

306 views
11:58

ASCO® 2024 Insights: "5-Year Results From the Randomized DYNAMIC Tri…

2024 ASCO® Annual Meeting Insights Hub

J. Tie

552 views
24:57

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

560 views
16:57

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

680 views
13:29

Treating KRAS-Mutated mCRC

Ibrahim Sahin

697 views
23:58

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

3.1K views
15:51

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey

488 views
11:33

Using ctDNA to Guide Adjuvant Therapy in GI Malignancies

University of Miami Sylvester Comprehensive Cancer Center

P. Hosein

322 views
22:33

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Integrity CE

V. Lee, R. Kumar, N. Bhagat, E. Winslow

372 views
09:32

ASCO® GI 2024 Panel Discussion: "ctDNA in Colon Cancer - GALAXY, BES…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

599 views
31:28

Year in Review: ctDNA in Colorectal Cancer

Weill Cornell Medicine Oncology & Hematology

P. Kasi

606 views
14:02

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

203 views
13:47

Neoadjuvant IO in MSI-High GI Cancers: Special Focus on the DREAM GI…

Aditya Shreenivas

S. Chakrabarti

532 views
25:50

Using ctDNA to Drive Decision Making in Adjuvant Chemotherapy of Col…

Scripps Health

S. Cohen

450 views
15:31

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

306 views
AUTOPLAY